# Abacavir

NDC: 69097-514
Generic name: Abacavir
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20171121

FDA application: ANDA078119

## Active ingredients

- ABACAVIR SULFATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-514"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-514
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d791375-e311-41f9-87b8-940657e6318c